Empiric Antibiotic Therapy for Osteomyelitis of the Feet

Pathogen Considerations for Empiric Therapy

Staphylococcus aureus, including MRSA, is the most common pathogen in osteomyelitis of the feet and must be covered in all empiric regimens, according to the Infectious Diseases Society of America 1, 2
Gram-negative organisms are also common in diabetic foot osteomyelitis, particularly in moderate to severe infections, necessitating broad-spectrum coverage initially, as recommended by the International Working Group on the Diabetic Foot 2, 3
Empiric anti-pseudomonal therapy is not routinely required in temperate climates unless the patient has had Pseudomonas isolated from the affected site within the previous few weeks or resides in Asia or North Africa, based on guidelines from the Infectious Diseases Society of America 2, 4
Anaerobic coverage should be added for necrotic, gangrenous, or foul-smelling wounds, as suggested by the Society for Healthcare Epidemiology of America 5

The American College of Clinical Pharmacy recommends vancomycin plus cefepime as a first-line regimen for empiric treatment of osteomyelitis of the feet 1
Alternative regimens include vancomycin plus ciprofloxacin or vancomycin plus a carbapenem, as recommended by the Infectious Diseases Society of America 1

Initial parenteral therapy should be continued for approximately 1-2 weeks before considering transition to oral antibiotics with good bioavailability, according to the International Working Group on the Diabetic Foot 1
Total duration for osteomyelitis without surgical resection is typically 6 weeks, as recommended by the Infectious Diseases Society of America 1, 4
If infected bone is surgically removed completely, a shorter course of 2-3 weeks may be sufficient, based on guidelines from the Society for Healthcare Epidemiology of America 4, 1

The Infectious Diseases Society of America recommends obtaining bone cultures before starting antibiotics to guide definitive therapy 6, 3
Modify empiric therapy based on culture results and clinical response, as suggested by the American College of Clinical Pharmacy 3

Follow inflammatory markers to assess response to treatment, according to the International Working Group on the Diabetic Foot 2, 6
If infection fails to respond after 4 weeks of appropriate therapy, re-evaluate the patient and consider discontinuing antibiotics temporarily to obtain new culture specimens or additional diagnostic studies, as recommended by the Infectious Diseases Society of America 2, 3

Urgent surgical consultation should be obtained for severe infections or moderate infections complicated by extensive gangrene, necrotizing infection, deep abscess, or compartment syndrome, according to the Society for Healthcare Epidemiology of America 2, 4
Consider surgical debridement in combination with antibiotics for moderate and severe infections to remove infected and necrotic tissue, as recommended by the International Working Group on the Diabetic Foot 2

Failing to obtain bone cultures before starting antibiotics, as warned by the Infectious Diseases Society of America 6
Using topical antibiotics in combination with systemic antibiotics, which is not recommended by the American College of Clinical Pharmacy 2
Treating for too short a duration, especially in cases without complete surgical removal of infected bone, according to the Infectious Diseases Society of America 4
Not considering vascular status and need for revascularization in patients with peripheral arterial disease, as emphasized by the International Working Group on the Diabetic Foot 2, 3